NCT06480123View on ClinicalTrials.gov

Stem Cell Derived Exome for Treatment of Diabetic Foot

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

December 30, 2028

Study Completion Date

December 30, 2033

Conditions
Diabetic FootStem Cell
Interventions
DRUG

Skin drug prepared with exome originated from stem cell

Skin drug prepared with exome originated from stem cell will be applied to patient with diabetic foot.

Trial Locations (1)

510260

The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors
lead

Second Affiliated Hospital of Guangzhou Medical University

OTHER

NCT06480123 - Stem Cell Derived Exome for Treatment of Diabetic Foot | Biotech Hunter | Biotech Hunter